Dr Satu Vainikka, CEO commented:

"I am delighted that we are now launching our Chlamydia self-testing product into the UK and Irish markets. With Chlamydia being diagnosed as the fastest growing sexually transmitted disease at the moment, our self-testing pack, as an affordable, easy -to-use and rapid indicator of the presence or absence of the Chlamydia bacterium has the potential to become a first line test against Chlamydia. With the disease having the potential to affect fertility in both sexes, I particularly urge young people looking to start a family to test themselves early. Early detection will mean early intervention and thinking that there is not a problem is just not thinking."

Broker Hybridan was positive about the launch, stating that ValiRx remains far from fully valued at these levels.

We like the model of product on the market generating revenues in the test kits and the more blue sky upside that its proprietary drug development programmes provide in the technology platform, said Hybridan.

Last month, ValiRx completed the sale of its Belgian diagnostic development business, ValiBIO SA, to Singapore Volition Pte Ltd, having received all the funds it was due.

ValiRx continues to retain its significant shareholding in Volition and in the future upside value and growth of the business and integration between the companies is progressing well

http://www.proactiveinvestors.co.uk/companies/news/25504/valirx-aim-stock-out-of-the-doldrums-25504.html

Have a peek at the interview with Dr George Morris - Link

Interesting recovery.

Yes..nice surprise..hope it continues!

Encouraging SP performance recently

One to hold for paying children education, IMO.

or grandchildren in my case!

Yes, off course dad.

Val stirring at long last!

DirectorsTalk.com – Investment analyst covering ValiRx Plc advises that the company will outperform the market.

"The one analyst offering a 12 month price target expects ValiRx Plc share price to rise to 2.16 in the next year from the last price of 0.48."

http://markets.ft.com/research/Markets/Tearsheets/Forecasts?s=VAL:LSE

Listen: ValiRx - New endometriosis patent grant

click here

more news regarding ValiSeek: http://brrmedia.co.uk/event/138620/dr-suzanne-dilly-ceo-valiseek-limited

bought some last week at 39p,, so far so good!